Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTao Liu

About this trial

This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

College student ≥18 years, all of whom have passed a standardized entrance examination;

No failed exams during the course of study;

Sleep deprivation;

In good health, with no mental or psychological disorders;

Disqualifiers

Pregnant or breastfeeding women.

Presence of acute or chronic medical conditions (e.g., severe hypertension, diabetes, cardiovascular disease) that could confound the results.

History of craniocervical trauma or surgery.

Current use of sedative or anxiolytic medications that could influence sleep or cognitive function.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD)

    Device

    Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

  • sham-intervention treatment

    Device

    Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: NSCLD groupExperimental treatment 1 intervention
Group B: Control groupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Digit Span Test

Evaluate memory function. 1 point for each correct string of numbers. Total score: forward score + backward score. Higher scores mean a better outcome.

Time frame
Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
2

Montreal Cognitive Assessment (MoCA)

The maximum score is 30 points. ≥26 points is normal. Higher scores mean a better outcome.

Time frame
Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

Secondary outcomes

1

Changes in anxiety, stress, irritability, etc. before and after instant massage

use Multidimensional VAS Battery. 0 points are "not at all", and 100 points are "extremely strong" (points 0- 100)

Time frame
Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
2

Brain metabolic markers and other metabolic indicators

Collect blood for analysis of Aβ42/40, T-Tau, p-tau217, Plasma cortisol, Salivary α-Amylase and β-Endorphin.

Time frame
Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
3

EEG power in alpha, beta, delta and theta band

Measure the power of different frequency bands of EEG and compare the changes.

Time frame
Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
4

Heart rate variability (HRV)

Analyze the different indicators of HRV, including RMSSD, LF, HF, LF/HF ratio, SDNN, etc.

Time frame
Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tao Liu

Lead sponsor

The George Institute

Sponsor institution

Tianjin Medical University General Hospital

Collaborator

Xuanwu Hospital, Beijing

Collaborator